CETIIRIZINE and PYREXIA

Overview

PYREXIA is the #9 most commonly reported adverse reaction for CETIIRIZINE, manufactured by Amneal Pharmaceuticals LLC. There are 3,653 FDA adverse event reports linking CETIIRIZINE to PYREXIA. This represents approximately 1.6% of all 233,494 adverse event reports for this drug.

Patients taking CETIIRIZINE who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for CETIIRIZINE, but still significant enough to appear in the safety profile.

Other Side Effects of CETIIRIZINE

In addition to pyrexia, the following adverse reactions have been reported for CETIIRIZINE:

• FATIGUE — 5,414 reports
• DRUG INEFFECTIVE — 4,954 reports
• PAIN — 4,810 reports
• RASH — 4,720 reports
• DYSPNOEA — 4,263 reports
• PRURITUS — 4,226 reports
• OFF LABEL USE — 4,108 reports
• ARTHRALGIA — 3,762 reports
• HYPERSENSITIVITY — 3,558 reports
• HEADACHE — 3,393 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does CETIIRIZINE cause PYREXIA?

PYREXIA has been reported as an adverse event in 3,653 FDA reports for CETIIRIZINE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with CETIIRIZINE?

PYREXIA accounts for approximately 1.6% of all adverse event reports for CETIIRIZINE, making it a notable side effect.

What should I do if I experience PYREXIA while taking CETIIRIZINE?

If you experience pyrexia while taking CETIIRIZINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages